WVE Wave Life Sciences Ltd

Wave Life Sciences Ltd is a preclinical therapeutics developer in Singapore. Its pipeline of drugs is intended to cure rare genetic disorders such as Huntington, duchenne muscular dystrophy (DMD) and inflammatory bowel disease.

$3.54  -0.07 (-1.94%)
As of 10/03/2022 15:59:45 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  Singapore
IPO date:  11/11/2015
Outstanding shares:  86,820,111
Average volume:  282,656
Market cap:   $307,343,193
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BYZG9R0
Valuation   (See tab for details)
PE ratio:   -2.67
PB ratio:   6.65
PS ratio:   7.20
Return on equity:   221,877.36%
Net income %:   -275.31%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy